Comorbilidades cardiovasculares y metabólicas | 15 MAR 21

Psoriasis en pediatría

Revisión sistemática y metaanálisis sobre la asociación de la psoriasis en pediatría y comorbilidades cardiovasculares y metabólicas.
Autor/a: Kevin Phan Geoffrey Lee Gayle Fischer  Pediatric Dermatology. 2020;37:661–669
INDICE:  1. Texto principal | 2. Referencias bibliográficas
Referencias bibliográficas

1. Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet. 2007;370:263-271.

2. Ryan C, Kirby B. Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities. Dermatol Clin. 2015;33:41-55.

3. Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res. 2007;298:321.

4. Johnston A, Arnadottir S, Gudjonsson JE, et al. Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation. Br J Dermatol. 2008;159:342-350.

5. Augustin M, Glaeske G, Radtke MA, Christophers E, Reich K, Schafer I. Epidemiology and comorbidity of psoriasis in children. Br J Dermatol. 2010;162:633-636.

6. Tollefson MM, Crowson CS, McEvoy MT, Maradit KH. Incidence of psoriasis in children: a population-based study. J Am Acad Dermatol. 2010;62:979-987.

7. Badaoui A, Tounian P, Mahe E. Psoriasis and metabolic and cardiovascular comorbidities in children: a systematic review. Arch Pediatr. 2019;26:86-94.

8. Koebnick C, Black MH, Smith N, et al. The association of psoriasis and elevated blood lipids in overweight and obese children. J Pediatr. 2011;159:577-583.

9. Jensen P, Zachariae C, Iversen L, Hansen PR, Skov L. Cardiovascular risk factors in children and adolescents with psoriasis: a case-control study. Acta Derm Venereol. 2014;94:76-78.

10. Paller AS, Mercy K, Kwasny MJ, et al. Association of pediatric psoriasis severity with excess and central adiposity: an international cross-sectional study. JAMA Dermatol. 2013;149:166-176.

11. Osier E, Wang AS, Tollefson MM, et al. Pediatric psoriasis comorbidity screening guidelines. JAMA Dermatol. 2017;153:698-704.

12. Au SC, Goldminz AM, Loo DS, et al. Association between pediatric psoriasis and the metabolic syndrome. J Am Acad Dermatol. 2012;66:1012-1013.

13. Boccardi D, Menni S, La Vecchia C, et al. Overweight and childhood psoriasis. Br J Dermatol. 2009;161:484-486.

14. Ergun T, Seckin Gencosmanoglu D, Karakoc-Aydiner E, et al. Prevalence of obesity in paediatric psoriasis and its impact on disease severity and progression. Australas J Dermatol. 2017;58:e182-e187.

15. Ferretti G, Simonetti O, Offidani AM, et al. Changes of plasma lipids and erythrocyte membrane fluidity in psoriatic children. Pediatr Res. 1993;33:506-509.

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

CONTENIDOS RELACIONADOS
AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024